| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/24/2010 | CN100591328C Cosmetic compositions containing chick pea extract and retinoids |
| 02/24/2010 | CN100591225C Composition containing isoflavone of high concentration and having high solubility, and process for producing the same |
| 02/23/2010 | USRE41150 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one |
| 02/23/2010 | US7667053 Cannabinoid-1 (CB1) receptor antagonists and/or inverse agonists; e.g. N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-1,4-benzodioxane-2-carboxamide; psychological disorders, eating disorders |
| 02/23/2010 | US7667052 Bioactive substance |
| 02/23/2010 | US7667041 Cinnamide compound |
| 02/23/2010 | US7667040 Azacyclic ethynyl derivatives |
| 02/23/2010 | US7667008 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 02/23/2010 | US7667007 αvβ3-specific antibodies |
| 02/23/2010 | US7667002 Peptides and proteins for early liver development and antibodies thereto |
| 02/23/2010 | US7666998 Cell growth inhibitor containing anti-PepT antibody |
| 02/23/2010 | US7666983 peptides that activate the DNA binding activity of the wild-type form of the p53 tumor suppressor, as well as of certain tumor-derived p53 mutants |
| 02/23/2010 | US7666900 ATP-binding cassette transport 1 (ABCA1) stabilizers; using probucol spiroquinone/probucol diphenoquinone as prophylactic/therapeutic agents to decrease ABCA1 expression; low-HDL (high-density lipoprotein) cholesterolemia; arteriosclerosis; pharmacogenetics |
| 02/23/2010 | US7666892 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12 |
| 02/23/2010 | US7666885 Enzyme inhibitors |
| 02/23/2010 | US7666881 4-(4-(4-(Hydroxydiphenylmethyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha -dimethylbenzene acetic acid hydrochloride formed by azeotropic distillation |
| 02/23/2010 | US7666876 Buprenorphine formulations for intranasal delivery |
| 02/23/2010 | US7666869 Nitrogen-containing 5-membered ring compound |
| 02/23/2010 | US7666867 Heteroindanes: a new class of potent cannabimimetic ligands |
| 02/23/2010 | US7666858 Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 02/23/2010 | US7666841 for the treatment of diseases and pathological alterations associated with excessive or deregulated TGF- beta 1 expression |
| 02/23/2010 | US7666647 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease |
| 02/23/2010 | US7666619 Compounds and methods for regulating bacterial growth and pathogenesis |
| 02/23/2010 | US7666439 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
| 02/23/2010 | US7666405 Deleted adenovirus vectors and methods of making and administering the same |
| 02/23/2010 | US7666401 Compositions comprising a ligand of Chemerin R |
| 02/23/2010 | CA2442974C Use of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of cell proliferation diseases |
| 02/23/2010 | CA2433021C Isoindole-imide compounds, compositions, and uses thereof |
| 02/23/2010 | CA2400826C Methods and compositions for treating intervertebral disc degeneration |
| 02/23/2010 | CA2389743C Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 02/23/2010 | CA2378880C Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 02/23/2010 | CA2355834C Human akt-3 |
| 02/23/2010 | CA2335461C Calcium channel blockers |
| 02/23/2010 | CA2329930C Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 02/23/2010 | CA2319916C Use of dhea, its precursors or its metabolic derivatives as a depigmentation agent |
| 02/23/2010 | CA2297115C Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 02/18/2010 | WO2010018856A1 Prophylactic/ameliorating or therapeutic agent for cannabinoid receptor-related disease |
| 02/18/2010 | WO2010018847A1 Recombinant protein-s composition |
| 02/18/2010 | WO2010018837A2 Protein cross-linking inhibitor |
| 02/18/2010 | WO2010018836A2 Polyglutamine aggregation inhibitor |
| 02/18/2010 | WO2010018800A1 Acetyl pyrrolidinyl indole derivative |
| 02/18/2010 | WO2010018614A1 Hydrophilic amino acid-containing preparation having improved taste |
| 02/18/2010 | WO2010018222A1 Nanocrystal nano-emulsion |
| 02/18/2010 | WO2010018216A2 Fluorescent emulsion of indocyanine green |
| 02/18/2010 | WO2009155611A9 Compositions for the treatment of fibrotic diseases or conditions |
| 02/18/2010 | US20100041708 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for it's preparation |
| 02/18/2010 | US20100041683 Novel chain-breaking antioxidants |
| 02/18/2010 | US20100041676 Kinase inhibitors |
| 02/18/2010 | US20100041671 Methods for treating glaucoma |
| 02/18/2010 | US20100041660 Novel 2-pyridinecarboxamide derivatives |
| 02/18/2010 | US20100041642 Urea inhibitors of map kinases |
| 02/18/2010 | US20100041639 Cyclic malonamides as inhibitors of a beta protein production |
| 02/18/2010 | US20100041624 Buprenorphine formulations for intranasal delivery |
| 02/18/2010 | US20100041607 Unctuous compositions |
| 02/18/2010 | US20100041597 Peptides targeted to protein kinase c isoforms and uses thereof |
| 02/18/2010 | US20100041151 Compositions and methods for treating lysosomal storage disease |
| 02/18/2010 | US20100041136 Connective Tissue Growth Factor-2 |
| 02/18/2010 | US20100041072 Process for identifying a ligand that binds to the nep binding site for the smr1 pentapeptide |
| 02/18/2010 | US20100041028 Zinc finger binding domains for GNN |
| 02/18/2010 | US20100040692 Two phase bioactive formulations |
| 02/18/2010 | US20100040673 Hygiene tissue comprising a microbe-inhibiting composition |
| 02/18/2010 | US20100040627 Baff receptor (bcma), an immunoregulatory agent |
| 02/18/2010 | US20100040598 Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient |
| 02/18/2010 | US20100040573 Cationic polymers as thickeners for aqueous and alcoholic compositions |
| 02/18/2010 | US20100040542 Chelator conjugates |
| 02/18/2010 | CA2733959A1 Nanocrystal nano-emulsion |
| 02/18/2010 | CA2733942A1 Fluorescent emulsion of indocyanine green |
| 02/18/2010 | CA2733646A1 Acetyl pyrrolidinyl indole derivative |
| 02/17/2010 | EP2154139A1 Bicyclic heterocyclic compound |
| 02/17/2010 | EP2154131A1 G protein-coupled receptor inhibitor and pharmaceutical product |
| 02/17/2010 | EP2153847A1 Gene sensitive to bone/joint disease and use thereof |
| 02/17/2010 | EP2153843A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/17/2010 | EP2153838A1 Anti-norovirus agent, and composition comprising the same |
| 02/17/2010 | EP2153819A2 Compositions containing therapeutically active components having enhanced solubility |
| 02/17/2010 | EP2153736A1 Novel leukotriene receptor antagonist |
| 02/17/2010 | EP2152748A1 Anti-notch1 nrr antibodies and methods using same |
| 02/17/2010 | EP2152663A2 Tri-aryl compounds and compositions comprising the same |
| 02/17/2010 | EP1549322B1 Lipid a and other carbohydrate ligand analogs |
| 02/17/2010 | EP1511737B1 Aryloximes |
| 02/17/2010 | EP1490013B1 Methods for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising hydroxyurea |
| 02/17/2010 | EP1487810B1 4-(diarylmethyl)-1-piperazinyl derivatives |
| 02/17/2010 | EP1420775B1 Platinum complexes and their uses in therapy |
| 02/17/2010 | CN100590133C Growth hormone and serum albumni recombinant fusion protein |
| 02/17/2010 | CN100590131C Methods and compounds for the targeting of protein to exosomes |
| 02/17/2010 | CN100589812C Plant worms mycelium extracat fraction and composition for oral intake |
| 02/16/2010 | US7662974 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 02/16/2010 | US7662932 Endothelial growth factor; isolated polypeptide; stimulate cell proliferation, neovascularization, vascular system permeability |
| 02/16/2010 | US7662854 HIF hydroxylase inhibitors |
| 02/16/2010 | US7662851 Use of specific cyklolignans |
| 02/16/2010 | US7662843 Isoxazoline compounds having MIF antagonist activity |
| 02/16/2010 | US7662840 4-{5-[4-(5-Isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine or N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine (DW-1350); a leukotriene-B4 receptor antangonist; inhibiting osteoclastic bone absorption |
| 02/16/2010 | US7662835 Methods of treating allergic reactions using an anhydrous form of antihistaminic piperidine derivatives |
| 02/16/2010 | US7662826 Pyrazolo [1,5-a] pyrimidine derivative and nad (p) h oxidase inhibitor containing the same |
| 02/16/2010 | US7662817 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever; irritable bowel syndrome |
| 02/16/2010 | US7662798 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
| 02/16/2010 | US7662782 Melanocortin 1 receptor selective compounds |
| 02/16/2010 | US7662775 Method for screening agents for the treatment of diabetes |
| 02/16/2010 | US7662633 Method of screening for inhibitors of osteopontin |
| 02/16/2010 | US7662553 Polymorphisms in the ERCC1 gene for predicting treatment outcome |
| 02/16/2010 | US7662403 Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof |